In addition, ADAM17 is correlated with a high tumor grade and poor prognosis in patients with glioma and may be a potential diagnostic and therapeutic target, whereas ADAM10 is associated with glioma grade in glioma growth and development, particularly the invasiveness of the glioma. Here, ADAM17 is linked to glioma.